Miles de libros con descuento a un solo clic en Buscalibre.com  Ver más

Enviar a
CUAUHTÉMOC, Ciudad de México
0
  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional

Selecciona tu país

América

Europa

Resto del mundo

portada Prostate-Specific Antigen-Based Screening for Prostate Cancer: An Evidence Update for the U.S. Preventive Services Task Force: Evidence Synthesis Numb (en Inglés)
Formato
Libro Físico
Editorial
Idioma
Inglés
N° páginas
62
Encuadernación
Tapa Blanda
Dimensiones
28.0 x 21.6 x 0.3 cm
Peso
0.17 kg.
ISBN13
9781484907849

Prostate-Specific Antigen-Based Screening for Prostate Cancer: An Evidence Update for the U.S. Preventive Services Task Force: Evidence Synthesis Numb (en Inglés)

U. S. Department of Heal Human Services (Autor) · Agency for Healthcare Resea And Quality (Autor) · Createspace · Tapa Blanda

Prostate-Specific Antigen-Based Screening for Prostate Cancer: An Evidence Update for the U.S. Preventive Services Task Force: Evidence Synthesis Numb (en Inglés) - And Quality, Agency for Healthcare Resea ; Human Services, U. S. Department of Heal

Libro Nuevo Importado
Envío: 17 a 22 días háb.
$ 917.39$ 458.69
-50%
Costos de importación incluídos en el precio ✅
Libro Nuevo

Quedan 100 unidades

$ 458.69
Llega entre el 14 Jul y el 22 Jul a CUAUHTÉMOC, Ciudad de México. Seleccionar ubicación

Reseña del libro "Prostate-Specific Antigen-Based Screening for Prostate Cancer: An Evidence Update for the U.S. Preventive Services Task Force: Evidence Synthesis Numb (en Inglés)"

The American Cancer Society estimates that in 2011, about 241,000 men will be diagnosed with prostate cancer and 34,000 men will die from it, making it the most commonly diagnosed nonskin cancer and the second leading cause of cancer death in men. Prostate-specific antigen (PSA)-based screening programs have been advocated as a possible means to reduce the mortality rate, as the test can detect asymptomatic, early-stage tumors. Beginning in the 1990s, utilization of the PSA test became widespread in U.S. clinical practice; data from nationally representative surveys and community primary care clinics consistently show that the majority of American men aged 50 years and older receive regular PSA tests. This evidence update summarizes new and previously reviewed randomized controlled trials, systematic reviews, and meta-analyses to answer the following key questions: 1) Does PSA-based screening decrease prostate cancer-specific or all-cause mortality? and 2) What are the harms of PSA-based screening for prostate cancer? "PSA-based screening" is defined as a screening program for prostate cancer in asymptomatic men that incorporates one or more PSA measurements, with or without additional modalities such as digital rectal examination or transrectal ultrasonography. "Asymptomatic" is defined as without symptoms that are highly suspicious for prostate cancer. Many older men have chronic, stable lower urinary tract symptoms (e.g., due to benign prostatic hyperplasia ) that are not generally associated with an increased risk for prostate cancer. As in a previous review for the USPSTF, a broad definition of PSA-based screening was utilized that includes traditional single-threshold PSA testing as well as other PSA-based prognostic measures, such as age-adjusted thresholds, velocity, and doubling time.

Opiniones del libro

Preguntas frecuentes sobre el libro

Todos los libros de nuestro catálogo son Originales.
El libro está escrito en Inglés.
La encuadernación de esta edición es Tapa Blanda.

Preguntas y respuestas sobre el libro

¿Tienes una pregunta sobre el libro? Inicia sesión para poder agregar tu propia pregunta.

Opiniones sobre Buscalibre

Ver más opiniones de clientes